3.9 Letter

Bladder cancer with secondary muscle invasion - a prognostic dilemma

Related references

Note: Only part of the references are listed.
Review Urology & Nephrology

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)

Marko Babjuk et al.

Summary: The updated EAU guidelines provide new information on the diagnosis and treatment of NMIBC for clinical practice. Individual risk assessment is crucial in determining the appropriate treatment for patients with different risk levels. Surgical intervention, including radical cystectomy, may be necessary for cases unresponsive to BCG treatment or with high risk of progression.

EUROPEAN UROLOGY (2022)

Article Urology & Nephrology

Comparative Outcomes of Primary Versus Recurrent High-risk Non-muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study

Nico C. Grossmann et al.

Summary: This study compared outcomes of radical cystectomy (RC) in patients with different stages of bladder cancer. It found that patients with recurrent non-muscle-invasive bladder cancer (NMIBC) had similar survival outcomes to those with primary muscle-invasive bladder cancer (MIBC), while patients with secondary MIBC had the worst outcomes.

EUROPEAN UROLOGY OPEN SCIENCE (2022)

Article Urology & Nephrology

A population-based study on the effect of a routine second-look resection on survival in primary stage T1 bladder cancer

Johannes Bobjer et al.

Summary: The study found similar survival outcomes in patients with and without second-look resection in stage T1 bladder cancer, but acknowledged the potential impact of selection mechanisms and called for a randomized study to define the role of SLR in stage T1 BCa.

SCANDINAVIAN JOURNAL OF UROLOGY (2021)

Article Oncology

Survival after cystectomy for invasive bladder cancer

R. R. de Vries et al.